Literature DB >> 3340827

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes.

K Lövgren1.   

Abstract

Immunostimulating complexes (iscoms) were prepared from influenza virus glycoproteins (A/PR8(H1N1]. Mice were inoculated with iscoms by local (oral or intranasal) as well as by subcutaneous administration. It was shown that one subcutaneous or intranasal inoculation induced serum antibody responses of similar magnitude. The intranasal administration, however, induced somewhat higher IgA and IgM titres than that induced subcutaneously. After a second intranasal or subcutaneous inoculation a prominent increase of the IgG isotypes was found. The secondary IgA and IgM responses were of similar magnitude as those induced after the primary inoculation. The antibody responses induced were evenly distributed within the IgG isotypes, although the highest titres recorded were of the IgG1 and IgG2 isotypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340827     DOI: 10.1111/j.1365-3083.1988.tb02343.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.

Authors:  A M Mowat; A M Donachie; G Reid; O Jarrett
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

2.  The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.

Authors:  E T Ben Ahmeida; R Jennings; M Erturk; C W Potter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.

Authors:  K Lövgren; H Kåberg; B Morein
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

4.  Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.

Authors:  H Yasui; J Kiyoshima; T Hori; K Shida
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

5.  The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.

Authors:  K F Hu; M Elvander; M Merza; L Akerblom; A Brandenburg; B Morein
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.

Authors:  H O Ghazi; M Erturk; L M Stannard; M Faulkner; C W Potter; R Jennings
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 7.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

8.  Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.

Authors:  K Scheepers; H Becht
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

9.  Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064.

Authors:  H Yasui; N Nagaoka; K Hayakawa
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

10.  PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens.

Authors:  Nelson F Eng; Srinivas Garlapati; Volker Gerdts; Lorne A Babiuk; George K Mutwiri
Journal:  J Immune Based Ther Vaccines       Date:  2010-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.